HONG KONG, GERMANTOWN, Md., and SUZHOU, China, /PRNewswire/ -- Sirnaomics Ltd. (the 'Company', Stock Code: 2257, together with its subsidiaries, the 'Group' or 'Sirnaomics'), a leading ...

The accumulation of SIRT4 in the nuclei of kidney cells drives kidney fibrosis, so blocking the movement of this protein could be a potential therapeutic strategy against fibrosis.

当中国投资人认定小核酸药物会成为未来最有前景的创新技术之一，头顶“中国核酸药物第一股”光环的圣诺医药（02257.HK）却深陷危机之中。 今年8月末，圣诺医药公布2024年中期业绩，财报数据显示，今年上半年，公司并无产生任何产品销售收入，录得亏损4350万美元，上年同期为亏损4110万美元。

当中国投资人认定小核酸药物会成为未来最有前景的创新技术之一，头顶“中国核酸药物第一股”光环的圣诺医药（02257.HK）却深陷危机之中。

One area of interest is the possibility of using the protein transforming growth factor (TGF)-β1 to assist with cartilage repair and in what circumstances this protein can be most effective.

The movement within supramolecular assemblies is critical to their biological activity, including their ability to regenerate cartilage and repair spinal cord damage. The finding suggests that ...

The researchers observed differences between the 2 subgroups, with logistic regression identifying significant differences in TGF-β1 and OPG. Immunosuppression status was also associated with ...

The gut microbiota and its functional metabolites play crucial roles in the development of intestinal fibrosis in patients ...

2018年1月19日，南方医科大学萍乡医院 (萍乡市人民医院)泌尿外科在Medical Science Monitor (中科院四区 IF=2.2)期刊上在线发表题为 "GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through ...

Transforming growth factor (TGF)-β1 and TGF-β2 have been implicated in the development of CCH in rodent models; a UK study has now found that high TGF-β levels predict the development of CCH ...

在第二届国际心血管代谢大会上，山东大学齐鲁医院张运院士就钠尿肽受体 C（NPRC）作为动脉粥样硬化性心血管疾病（ASCVD）干预的新靶点进行了深入阐述。报告围绕 NPRC ...